Ani Pharmaceuticals (ANIP) Liabilities from Discontinued Operations (2012 - 2013)
Ani Pharmaceuticals (ANIP) posted Liabilities from Discontinued Operations of 131613.0 for Q3 2013, down 64.08% sequentially from 366390.0 in Q2 2013.
Ani Pharmaceuticals (ANIP) Liabilities from Discontinued Operations (2012 - 2013) Analysis & Trends
Ani Pharmaceuticals has reported Liabilities from Discontinued Operations for 2 years, with the latest figure at 131613.0 in Q3 2013.
- Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 131613.0 in Q3 2013, while the trailing twelve-month figure through Sep 2013 was 131613.0 (changed N/A YoY) and the FY2012 annual result came in at 370766.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations eased to 131613.0 in Q3 2013 per ANIP's latest filing, from 366390.0 in the prior quarter.
- Over five years, Liabilities from Discontinued Operations peaked at 370766.0 in Q4 2012 and troughed at 131613.0 in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | 131,613.00 |
| Sep 30, 2013 | 131,613.00 |
| Jun 30, 2013 | 366,390.00 |
| Jun 30, 2013 | 366,390.00 |
| Dec 31, 2012 | 370,766.00 |
| Dec 31, 2012 | 370,766.00 |